Literature DB >> 15543006

Long-term outcome of chronic idiopathic thrombocytopenic purpura in children.

Somasundaram Jayabose1, Oya Levendoglu-Tugal, Mehmet F Ozkaynkak, Paul Visintainer, Claudio Sandoval.   

Abstract

OBJECTIVES: Children with chronic idiopathic thrombocytopenic purpura (ITP) generally have a favorable outcome, but it is not known whether there are any prognostic factors to predict outcome. The objectives of this study were to assess the spontaneous remission rate and the prognostic significance of age, gender, initial platelet count, initial treatment, and response to treatment.
METHODS: In this retrospective review of 62 consecutive children with chronic ITP, 37 were girls and 27 were 10 years of age or older (median age 9 years; range, 0.75-19).
RESULTS: Thirty-five patients (56%) achieved spontaneous remission (remission without splenectomy), 30 of them (48%) within 4 years from diagnosis. Twenty-eight (45%) were complete remissions (platelet counts of >/=100,000) and 7 (11%) were partial remissions (50,000-99,000). There was no significant difference in the spontaneous remission rate between the younger (<10 years) and older children (55.8% vs. 57.1%, P = 0.95) or between boys and girls (56% vs. 56.7%, P = 0.98). Similarly, platelet count at initial diagnosis, initial therapy, or response to initial therapy did not have any prognostic significance. All 14 patients who underwent splenectomy achieved complete remission.
CONCLUSIONS: More than 50% of children with chronic ITP achieve spontaneous remission. Age, gender, platelet count at initial diagnosis, initial treatment, and response to initial treatment do not have any prognostic significance toward the outcome of chronic ITP.

Entities:  

Mesh:

Year:  2004        PMID: 15543006     DOI: 10.1097/00043426-200411000-00007

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  6 in total

1.  Consensus Paper-ICIS Expert Meeting Basel 2009 treatment milestones in immune thrombocytopenia.

Authors:  Hannah Tamary; Jelena Roganovic; Meera Chitlur; Diane J Nugent
Journal:  Ann Hematol       Date:  2010-04-01       Impact factor: 3.673

2.  Long-term outcome of otherwise healthy individuals with incidentally discovered borderline thrombocytopenia.

Authors:  Roberto Stasi; Sergio Amadori; John Osborn; Adrian C Newland; Drew Provan
Journal:  PLoS Med       Date:  2006-03       Impact factor: 11.069

3.  Association of CD4(+)CD25(+)FoxP3(+) regulatory T cells with natural course of childhood chronic immune thrombocytopenic purpura.

Authors:  Bo Ra Son; Ji Yoon Kim
Journal:  Korean J Pediatr       Date:  2015-05-22

4.  Guidelines on the diagnosis of primary immune thrombocytopenia in children and adolescents: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines Project: Associação Médica Brasileira - 2012.

Authors:  Josefina Aparecida Pellegrini Braga; Sandra Regina Loggetto; Andrea Thives de Carvalho Hoepers; Wanderley Marques Bernardo; Leticia Medeiros; Mônica Pinheiro de Almeida Veríssimo
Journal:  Rev Bras Hematol Hemoter       Date:  2013

5.  Natural course of childhood chronic immune thrombocytopenia using the revised terminology and definitions of the international working group: a single center experience.

Authors:  Ye Jee Shim; Uk Hyun Kim; Jin Kyung Suh; Kun Soo Lee
Journal:  Blood Res       Date:  2014-09-25

6.  Long-term results of laparoscopic splenectomy in pediatric chronic immune thrombocytopenic purpura.

Authors:  Dong Jin Kim; Jae Hee Chung
Journal:  Ann Surg Treat Res       Date:  2014-05-23       Impact factor: 1.859

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.